Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPOT feasibility study in organ transplant recipients
2013-000893-32Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Oct 2013
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in actinic keratosis (AK) and cutaneous squamous cell carcinoma (cSCC) comparing Imiquimod topical treatment with Fluorouracil topical treatment (2 arms). Primary endpoint: Feasibility of phase III trial. Started Oct 2013; status: completed.
02
Drugs
imiquimodfluorouracil
03
Conditions
actinic keratosis (AK)cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on 2013-000893-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000893-32.